Masimo Competitors

MASI Stock  USD 178.24  -0.46  -0.26%   
The company conducts business in the Health Care Equipment & Supplies sector. Within this framework, Masimo is compared with Avantor, AptarGroup, Baxter International, Abivax SA, and Bio Rad, along with other selected peers. This grouping supports side-by-side analysis across the sector. Financial data is sourced from standardized regulatory submissions. Masimo is contrasted with related stocks to identify relative positioning. This comparison view highlights where Masimo may show stronger fundamentals than peers.

Masimo and Molina Healthcare Correlation Overview

Excellent diversification
Across the chosen horizon, MASI and MOH show a correlation of -0.51 and fall into the Excellent diversification bucket. The cleaner interpretation is to review correlation beside volatility, expected return, and the role each holding plays in the portfolio.

Moving against Masimo Stock

  0.84QDEL QuidelPairCorr
  0.81NXGL Nexgel IncPairCorr
  0.78IINN Inspira Technologies OxyPairCorr
  0.72NXL Nexalin TechnologyPairCorr
  0.66HSDT Helius MedicalPairCorr
Specify up to 10 symbols:
Mean reversion in Masimo is more reliable over longer time horizons. Short-term deviations can persist and even widen before correcting, making position sizing and risk management critical.
Hype
Prediction
LowEstimatedHigh
173.58178.24182.90
Details
Intrinsic
Valuation
LowRealHigh
134.37139.03196.06
Details
Naive
Forecast
LowNextHigh
166.99171.65176.30
Details
Analyst
Consensus
LowTargetHigh
162.53178.60198.25
Details
Effective investment decisions about Masimo require competitive context. Benchmarking Masimo's against peers on earnings quality, growth consistency, and balance sheet strength can materially change the investment conclusion.

Masimo Competition Correlation Matrix

Competition correlation for Masimo matters because related securities often respond to the same industry, factor, or macro drivers even when their business stories differ. This matrix is most informative when investors want to know whether adding another peer would improve diversification, increase crowding, or leave total risk largely unchanged.

High positive correlations

RGENAVTR
BIOAVTR
RGENBIO
STVNRGEN
STVNBIO
STVNAVTR
  

High negative correlations

MOHATR
STVNATR
BIOATR
RGENATR
ATRAVTR
RYTMATR

Risk-Adjusted Indicators

There is a big difference between Masimo Stock performing well and Masimo Company doing well as a business compared to the competition. A thorough review of Masimo's risk-adjusted indicators provides a clearer picture of whether returns are being earned efficiently. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Peer Comparison: Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Masimo financial statement analysis. It represents the amount of money remaining after all of Masimo operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Compare Masimo and related stocks such as Avantor, AptarGroup, and Baxter International Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AGraham Number
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
20102011201220132014201520162017201820192020202120222023202420252026
AVTR21.6 M21.6 M21.6 M21.6 M21.6 M21.6 M-42.4 M-112.7 M-86.9 M37.8 M116.6 M572.6 M686.5 M321.1 M711.5 M-530.2 M-503.7 M
ATR19.5 M183.7 M162.6 M172 M191.7 M199.3 M205.6 M220 M194.7 M242.2 M214 M244.1 M239.3 M284.5 M374.5 M392.8 M412.4 M
BAX137 M2.2 B2.3 BB2.5 B968 MB602 M1.5 BB1.1 B1.3 B-2.4 B2.7 B-649 M-957 M-909.1 M
BIO4.3 M178.2 M169.2 M77.8 M88.8 M113.1 M28.1 M114.7 M361 M1.8 B3.8 B4.3 B-3.6 B-637.3 M-1.8 B759.9 M797.9 M
HSIC-10.9 M367.7 M388.1 M444.1 M466.1 M479.1 M506.8 M406.3 M535.9 M508 M402.2 M623.9 M538 M416 M390 M398 M306 M
RGEN-1.4 M-1.6 B14.2 M16.1 M8.2 M9.3 M11.7 M28.4 M16.6 M21.4 M59.9 M128.3 M186 M41.6 M-25.5 M48.9 M51.3 M
STVN39.2 M39.2 M39.2 M39.2 M39.2 M39.2 M39.2 M39.2 M39.2 M39.2 M78.5 M134.3 M142.8 M145.6 M117.8 M134.3 M124.5 M
MOH9.5 M20.8 M9.8 M52.9 M62.2 M143 MM-512 M707 M737 M673 M659 M792 M1.1 B1.2 B472 M267.2 M

Masimo Competitive Analysis

How does Masimo measure up against Avantor, AptarGroup, and Baxter International? The financials tell a nuanced story. Masimo operates at a 9.41 B scale with 1.53 B flowing through the income statement. With a -21.14% return on equity and -26.10% net margin, Masimo faces a more difficult earnings environment than some peers. Avantor leads on revenue, 6.55 B to 1.53 B, a substantial gap. Profit margins tilt toward AptarGroup at 10.40% against Masimo at -26.10%. Baxter International converts shareholder equity more efficiently at -13.71% versus Masimo at -21.14%.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
MASI AVTR ATR BAX ABVX BIO HSIC RGEN STVN RYTM
 0.26 
178.24
Masimo
 1.31 
7.51
Avantor
 2.35 
121.06
AptarGroup
 3.06 
16.15
Baxter
 2.19 
120.34
Abivax
 0.19 
264.49
Bio
 0.54 
72.29
Henry
 3.17 
113.88
Repligen
 3.76 
14.60
Stevanato
 3.17 
87.45
Rhythm
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Analysis
(Average Analysts Consensus)
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Five Year Return
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Last Dividend Paid
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Masimo Competition Peer Performance Charts

How to Analyze Masimo Against Peers

Masimo's peer analysis compares Masimo with related companies to put valuation, quality, and risk metrics in context. This helps determine whether recent performance is company-specific or broadly sector-driven. A practical workflow includes:
  • Set a relevant peer group: Include direct competitors and close alternatives with comparable business exposure.
  • Benchmark core financials: Compare profitability, growth, capital structure, and cash flow quality.
  • Check valuation dispersion: Review whether Masimo trades at a premium or discount versus peers and why.
  • Evaluate risk profile: Compare volatility, drawdowns, and correlation to avoid false diversification assumptions.
  • Document the thesis: Record where Masimo leads or lags and what catalysts could close or widen the gap.
Use this as an educational baseline, then validate conclusions with current filings, market conditions, and portfolio objectives.

Peer Comparison Metrics & Methodology

Peer analysis for Masimo benchmarks it against the companies that most directly compete for the same customers, capital, and market share. The peer benchmarking view is most useful when filtered by business model similarity rather than just Masimo's sector classification. Companies that appear similar on revenue growth may differ substantially on Masimo's margin and return profile. The information is analytical in nature and is not intended as a specific recommendation. The peer set can help frame whether recent outperformance is broad-based or company-specific. For peer comparison, Masimo has a market cap of 9.41 B, P/E of 35.69, profit margin of -26.1%.

The analytics block for Masimo relies on periodic company reporting and market reference feeds, with quality checks and normalization applied before rendering. Timing can vary by data vendor.

This content is curated and reviewed by:

Rifka Kats - Member of Macroaxis Editorial Board
Last reviewed on March 6th, 2026